Inability to use renal biomarkers such as neutrophil gelatinase-associated lipocalin (NGAL), Interleukin-18 (IL-18), Kidney injury molecule 1(KIM-1), Cystatin C, Urinary microRNA, etc., which are more sensitive for the diagnosis of AKI. This evidence concerns the gene LCN2 and acute kidney injury.